Press release content from PR Newswire. The AP news staff was not involved in its creation. Galaxy Medical ECLIPSE-AF Study to be Featured in Innovative Technology Session at EHRA 2021 Annual Scientific Meeting April 22, 2021 GMT SAN CARLOS, Calif., April 22, 2021 /PRNewswire/ -- Galaxy Medical announced today that the acute results of its Europe-focused ECLIPSE-AF study will be featured during the upcoming EHRA Congress in a innovative Technology presentation on April 25th by Ante Anić, M.D., Electrophysiology Laboratory Director at University Clinical Hospital in Split, Croatia, and primary investigator of the study. The ECLIPSE-AF Trial launched in September 2020 to study the acute safety of Galaxy’s flagship CENTAURI™ System, which uses Pulsed Electric Field (PEF) technology to treat cardiac arrhythmias. PEF targets arrhythmias by delivering quick bursts of high-voltage, high-frequency energy to ablate the heart. Two major innovations are unique to the CENTAURI system: